Literature DB >> 22862944

Regulation of embryonic and induced pluripotency by aurora kinase-p53 signaling.

Dung-Fang Lee1, Jie Su, Yen-Sin Ang, Xonia Carvajal-Vergara, Sonia Mulero-Navarro, Carlos F Pereira, Julian Gingold, Hung-Liang Wang, Ruiying Zhao, Ana Sevilla, Henia Darr, Andrew J K Williamson, Betty Chang, Xiaohong Niu, Francesca Aguilo, Elsa R Flores, Yuh-Pyng Sher, Mien-Chie Hung, Anthony D Whetton, Bruce D Gelb, Kateri A Moore, Hans-Willem Snoeck, Avi Ma'ayan, Christoph Schaniel, Ihor R Lemischka.   

Abstract

Many signals must be integrated to maintain self-renewal and pluripotency in embryonic stem cells (ESCs) and to enable induced pluripotent stem cell (iPSC) reprogramming. However, the exact molecular regulatory mechanisms remain elusive. To unravel the essential internal and external signals required for sustaining the ESC state, we conducted a short hairpin (sh) RNA screen of 104 ESC-associated phosphoregulators. Depletion of one such molecule, aurora kinase A (Aurka), resulted in compromised self-renewal and consequent differentiation. By integrating global gene expression and computational analyses, we discovered that loss of Aurka leads to upregulated p53 activity that triggers ESC differentiation. Specifically, Aurka regulates pluripotency through phosphorylation-mediated inhibition of p53-directed ectodermal and mesodermal gene expression. Phosphorylation of p53 not only impairs p53-induced ESC differentiation but also p53-mediated suppression of iPSC reprogramming. Our studies demonstrate an essential role for Aurka-p53 signaling in the regulation of self-renewal, differentiation, and somatic cell reprogramming.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22862944      PMCID: PMC3413175          DOI: 10.1016/j.stem.2012.05.020

Source DB:  PubMed          Journal:  Cell Stem Cell        ISSN: 1875-9777            Impact factor:   24.633


  63 in total

1.  Combining competition assays with genetic complementation strategies to dissect mouse embryonic stem cell self-renewal and pluripotency.

Authors:  Dung-Fang Lee; Jie Su; Ana Sevilla; Julian Gingold; Christoph Schaniel; Ihor R Lemischka
Journal:  Nat Protoc       Date:  2012-03-22       Impact factor: 13.491

2.  A human iPSC model of Hutchinson Gilford Progeria reveals vascular smooth muscle and mesenchymal stem cell defects.

Authors:  Jinqiu Zhang; Qizhou Lian; Guili Zhu; Fan Zhou; Lin Sui; Cindy Tan; Rafidah Abdul Mutalif; Raju Navasankari; Yuelin Zhang; Hung-Fat Tse; Colin L Stewart; Alan Colman
Journal:  Cell Stem Cell       Date:  2010-12-23       Impact factor: 24.633

Review 3.  Transcriptional control of human p53-regulated genes.

Authors:  Todd Riley; Eduardo Sontag; Patricia Chen; Arnold Levine
Journal:  Nat Rev Mol Cell Biol       Date:  2008-05       Impact factor: 94.444

4.  FOXO1 is an essential regulator of pluripotency in human embryonic stem cells.

Authors:  Xin Zhang; Safak Yalcin; Dung-Fang Lee; Tsung-Yin J Yeh; Seung-Min Lee; Jie Su; Sathish Kumar Mungamuri; Pauline Rimmelé; Marion Kennedy; Rani Sellers; Markus Landthaler; Thomas Tuschl; Nai-Wen Chi; Ihor Lemischka; Gordon Keller; Saghi Ghaffari
Journal:  Nat Cell Biol       Date:  2011-07-31       Impact factor: 28.824

5.  Nucleolar Arf sequesters Mdm2 and activates p53.

Authors:  J D Weber; L J Taylor; M F Roussel; C J Sherr; D Bar-Sagi
Journal:  Nat Cell Biol       Date:  1999-05       Impact factor: 28.824

Review 6.  Stem cells and reprogramming: breaking the epigenetic barrier?

Authors:  Yen-Sin Ang; Alexandre Gaspar-Maia; Ihor R Lemischka; Emily Bernstein
Journal:  Trends Pharmacol Sci       Date:  2011-05-27       Impact factor: 14.819

7.  Wdr5 mediates self-renewal and reprogramming via the embryonic stem cell core transcriptional network.

Authors:  Yen-Sin Ang; Su-Yi Tsai; Dung-Fang Lee; Jonathan Monk; Jie Su; Kajan Ratnakumar; Junjun Ding; Yongchao Ge; Henia Darr; Betty Chang; Jianlong Wang; Michael Rendl; Emily Bernstein; Christoph Schaniel; Ihor R Lemischka
Journal:  Cell       Date:  2011-04-07       Impact factor: 41.582

Review 8.  Differentiation of embryonic stem cells to clinically relevant populations: lessons from embryonic development.

Authors:  Charles E Murry; Gordon Keller
Journal:  Cell       Date:  2008-02-22       Impact factor: 41.582

9.  SIRT1 regulates apoptosis and Nanog expression in mouse embryonic stem cells by controlling p53 subcellular localization.

Authors:  Myung-Kwan Han; Eun-Kyung Song; Ying Guo; Xuan Ou; Charlie Mantel; Hal E Broxmeyer
Journal:  Cell Stem Cell       Date:  2008-03-06       Impact factor: 24.633

10.  Module map of stem cell genes guides creation of epithelial cancer stem cells.

Authors:  David J Wong; Helen Liu; Todd W Ridky; David Cassarino; Eran Segal; Howard Y Chang
Journal:  Cell Stem Cell       Date:  2008-04-10       Impact factor: 24.633

View more
  78 in total

Review 1.  Roles of small molecules in somatic cell reprogramming.

Authors:  Jian-bin Su; Duan-qing Pei; Bao-ming Qin
Journal:  Acta Pharmacol Sin       Date:  2013-06-03       Impact factor: 6.150

Review 2.  The Role of the p53 Protein in Stem-Cell Biology and Epigenetic Regulation.

Authors:  Arnold J Levine; Anna M Puzio-Kuter; Chang S Chan; Pierre Hainaut
Journal:  Cold Spring Harb Perspect Med       Date:  2016-09-01       Impact factor: 6.915

3.  An Apela RNA-Containing Negative Feedback Loop Regulates p53-Mediated Apoptosis in Embryonic Stem Cells.

Authors:  Mangmang Li; Hongfeng Gou; Brajendra K Tripathi; Jing Huang; Shunlin Jiang; Wendy Dubois; Tim Waybright; Ming Lei; Jianxin Shi; Ming Zhou; Jing Huang
Journal:  Cell Stem Cell       Date:  2015-04-30       Impact factor: 24.633

4.  Tex10 Coordinates Epigenetic Control of Super-Enhancer Activity in Pluripotency and Reprogramming.

Authors:  Junjun Ding; Xin Huang; Ningyi Shao; Hongwei Zhou; Dung-Fang Lee; Francesco Faiola; Miguel Fidalgo; Diana Guallar; Arven Saunders; Pavel V Shliaha; Hailong Wang; Avinash Waghray; Dmitri Papatsenko; Carlos Sánchez-Priego; Dan Li; Ye Yuan; Ihor R Lemischka; Li Shen; Kevin Kelley; Haiteng Deng; Xiaohua Shen; Jianlong Wang
Journal:  Cell Stem Cell       Date:  2015-04-30       Impact factor: 24.633

Review 5.  Osteosarcoma: Molecular Pathogenesis and iPSC Modeling.

Authors:  Yu-Hsuan Lin; Brittany E Jewell; Julian Gingold; Linchao Lu; Ruiying Zhao; Lisa L Wang; Dung-Fang Lee
Journal:  Trends Mol Med       Date:  2017-07-20       Impact factor: 11.951

6.  Genetic instability of modified stem cells - a first step towards malignant transformation?

Authors:  Doris Steinemann; Gudrun Göhring; Brigitte Schlegelberger
Journal:  Am J Stem Cells       Date:  2013-03-08

7.  Rescue of embryonic stem cells from cellular transformation by proteomic stabilization of mutant p53 and conversion into WT conformation.

Authors:  Noa Rivlin; Shir Katz; Maayan Doody; Michal Sheffer; Stav Horesh; Alina Molchadsky; Gabriela Koifman; Yoav Shetzer; Naomi Goldfinger; Varda Rotter; Tamar Geiger
Journal:  Proc Natl Acad Sci U S A       Date:  2014-04-28       Impact factor: 11.205

8.  SETD6 monomethylates H2AZ on lysine 7 and is required for the maintenance of embryonic stem cell self-renewal.

Authors:  Olivier Binda; Ana Sevilla; Gary LeRoy; Ihor R Lemischka; Benjamin A Garcia; Stéphane Richard
Journal:  Epigenetics       Date:  2013-01-16       Impact factor: 4.528

9.  Aurora kinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancer.

Authors:  Warapen Treekitkarnmongkol; Hiroshi Katayama; Kazuharu Kai; Kaori Sasai; Jennifer Carter Jones; Jing Wang; Li Shen; Aysegul A Sahin; Mihai Gagea; Naoto T Ueno; Chad J Creighton; Subrata Sen
Journal:  Carcinogenesis       Date:  2016-09-13       Impact factor: 4.944

Review 10.  Protein kinases and associated pathways in pluripotent state and lineage differentiation.

Authors:  Melina Shoni; Kathy O Lui; Demetrios G Vavvas; Michael G Muto; Ross S Berkowitz; Nikolaos Vlahos; Shu-Wing Ng
Journal:  Curr Stem Cell Res Ther       Date:  2014       Impact factor: 3.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.